Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...
Connor Clark & Lunn Investment Management Ltd. Increases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – ...
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...
Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?
Xeris Biopharma (XERS) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...
Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game
We recently published a list of 12 Best Stocks to Invest in for a Stock Market Game. In this article, we are going to take a ...
Crain's Chicago Business6d
Xeris enters a whole new market for one of its main pharma offerings
Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...